Abstract
The bronchodilator and cardiac effects produced by aerosols of 0·5% salbutamol and 0·5% and 1% rimiterol administered for three minutes in 40% oxygen by intermittent positive-pressure ventilation (I.P.P.V.) were compared in 15 asthmatic patients. Salbutamol and both the concentrations of rimiterol were equipotent in peak bronchodilator effect, but salbutamol had a significantly longer duration of bronchodilator action. There was significantly less increase in heart rate after rimiterol than after salbutamol. Aerosols of 0·5% rimiterol, 0·5% salbutamol, and saline were administered by I.P.P.V. to 10 normal volunteers. There was no difference between the mean heart rates after 0·5% rimiterol and saline but a highly significant increase in mean heart rate was observed after 0·5% salbutamol. It was concluded that 0·5% rimiterol was an effective short-acting bronchodilator drug with little or no cardiac beta1-adrenergic activity when administered for three minutes by I.P.P.V. in 40% oxygen.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Carney I., Daly M. J., Lightowler J. E., Pickering R. W. The comparative pharmacology of WG253 (rimiterol hydrobromide), a new bronchodilator. Arch Int Pharmacodyn Ther. 1971 Dec;194(2):334–345. [PubMed] [Google Scholar]
- Choo-Kang Y. F., Parker S. S., Grant I. W. Response of asthmatics to isoprenaline and salbutamol aerosols administered by intermittent positive-pressure ventilation. Br Med J. 1970 Nov 21;4(5733):465–468. doi: 10.1136/bmj.4.5733.465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gailer K. A., Hornsey P. A., Turner P. The relative potency of some -adrenoreceptor agonists on isolated human vein. Eur J Pharmacol. 1971 Oct;16(2):136–141. doi: 10.1016/0014-2999(71)90002-1. [DOI] [PubMed] [Google Scholar]
- Laity J. L. A comparison of the effects of isoprenaline, WG 253 and salbutamol on the tension and rate of rabbit isolated atria. J Pharm Pharmacol. 1971 Aug;23(8):633–634. doi: 10.1111/j.2042-7158.1971.tb08733.x. [DOI] [PubMed] [Google Scholar]
- Phillips E. M., Woolnough M., Marinova V. M., Turner P. A comparison of isoprenaline, salbutamol, and rimiterol inhalation on skin temperature, heart rate, and respiration in man. J Clin Pharmacol New Drugs. 1972 Apr;12(4):158–168. doi: 10.1002/j.1552-4604.1972.tb00045.x. [DOI] [PubMed] [Google Scholar]
- Shenfield G. M., Paterson J. W. Clinical assessment of bronchodilator drugs delivered by aerosol. Thorax. 1973 Mar;28(2):124–128. doi: 10.1136/thx.28.2.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Svedmyr N., Malmberg R., Thiringer G. The effect of a new adrenergic beta 2 -receptor-stimulating agent (rimiterol, R798) in patients with chronic obstructive lung disease. Scand J Respir Dis. 1972;53(5):302–313. [PubMed] [Google Scholar]
- Turner P., Griffin J. P. Antagonism of acetylcholine-induced bronchospasm by WG 253, a new sympathomimetic amine. J Pharm Pharmacol. 1971 Aug;23(8):632–632. doi: 10.1111/j.2042-7158.1971.tb08732.x. [DOI] [PubMed] [Google Scholar]